TwinBeech Capital’s Amgen AMGN Stock Holding History

TwinBeech Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,187	Closed	-$9.21M	–	368
2026 Q1	$9.21M	Buy	+26,187	New	+$9.34M	0.95%	9
2025 Q3	–	Sell	-43,403	Closed	-$12.1M	–	556
2025 Q2	$12.1M	Buy	+43,403	New	+$12.3M	0.27%	103
2025 Q1	–	Sell	-5,204	Closed	-$1.36M	–	695
2024 Q4	$1.36M	Buy	5,204 +3,335	+178%	+$989K	0.02%	359
2024 Q3	$602K	Buy	+1,869	New	+$611K	0.01%	568
2023 Q2	–	Sell	-7,773	Closed	-$1.88M	–	577
2023 Q1	$1.88M	Buy	+7,773	New	+$1.91M	0.04%	382
2022 Q3	–	Sell	-1,030	Closed	-$251K	–	606
2022 Q2	$251K	Buy	+1,030	New	+$252K	0.01%	465
2021 Q3	–	Sell	-9,550	Closed	-$2.33M	–	562
2021 Q2	$2.33M	Buy	+9,550	New	+$2.35M	0.28%	116

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

TwinBeech Capital's AMGN Position: Q2 2026 in Review

TwinBeech Capital sold out of Amgen (AMGN) in Q2 2026, closing a stake of 26,187 shares — an estimated $9.21M sold.

TwinBeech Capital first reported a position in AMGN in Q2 2021 and held it in 7 quarters. The position peaked at $12.1M in Q2 2025. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

TwinBeech Capital reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
TwinBeech Capital sold 26,187 Amgen shares in Q2 2026, an estimated $9.21M.
TwinBeech Capital first reported a position in Amgen in Q2 2021 and held it in 7 quarters.
TwinBeech Capital's Amgen position peaked at $12.1M in Q2 2025.
3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.